As average ozone exposure in the first 2 years of life rose, so did the likelihood for caregiver-reported asthma and wheeze ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published in ...